Betamethasone complete at 27 weeks.
Growth restriction of Triplet #2 prompted cesarean section.
At delivery the patient was vigorous, given blow-by oxygen and stimulation.
The infant was brought to the Neonatal Intensive Care Unit for management of prematurity and respiratory distress.
HOSPITAL COURSE:  (By systems)  Respiratory - The infant initially on CPAP with an initial arterial blood gas of pH 7.14, CO2 70, pAO2 100, infant was then intubated and received two doses of Survanta.
The infant was weaned on ventilator settings and extubated to room air by day of life #1.
Repeat blood gas after intubation showed pH of 7.32, CO2 45.
Infant was started on caffeine citrate on day of life #4 for increased apnea and bradycardia.
Caffeine citrate was discontinued on [**11-17**], the last apnea and bradycardia was on [**11-16**].
Enteral feedings were started on day of life #1 at 30 cc/kg/day of premature Enfamil 20 calories/ounce or breastmilk 20 calories/ounce.
Feedings were advanced and intravenous fluid was discontinued by day of life #3.
Infant has advanced to 26 cal/oz by day of life #8 and is currently on 150 cc/kg/day of breastmilk 20 calories/ounce or Premature Enfamil 26 calories/ounce gavage.
Infant tolerated feeding advancement without difficulty.
Phototherapy was discontinued on day of life #6 and a rebound bilirubin on day of life #7, total was 7.3.
The infant did not require any transfusions this hospitalization.
Infectious disease - Due to prematurity and respiratory distress the infant was started on ampicillin and Gentamicin.
Antibiotics were discontinued after 48 hours and blood cultures remained negative to date.
Immunizations - The infant has not received any immunizations this hospitalization.
Immunizations recommended - Hepatitis B vaccine.
Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  I.
Status post direct hyperbilirubinemia 6.
